Clinical trial
Antibodies Causing Epilepsy Syndromes: The ACES Study.
NCT02802475 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Antibodies Causing Epilepsy Syndromes: The ACES Study.
- Lead sponsor
- Erasmus Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2014
- Completion date
- December 31, 2020
- Enrollment
- 582 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
auto-immune encephalitis, epilepsy